Key result
Isolated coronary artery spasm is linked to lower OHCA recurrence risk than Brugada syndrome.
Why the study?
Optimal therapy for OHCA survivors without structural heart disease remains to be established, particularly regarding implantable cardioverter-defibrillator use and the role of coronary artery spasm and ventricular arrhythmias.
Does dual induction testing for coronary artery spasm and programmed ventricular stimulation predict recurrence of ventricular fibrillation in OHCA survivors without structural heart disease?
Cohort (n=47)
Does dual induction testing for coronary artery spasm and programmed ventricular stimulation predict recurrence of ventricular fibrillation in OHCA survivors without structural heart disease?
In OHCA survivors without structural heart disease, dual induction testing identifies patients with coronary artery spasm alone (without Brugada syndrome) as a lower-risk group for recurrent ventricular fibrillation.
Answers are grounded in this paper and cite their sources.
May inform etiology-specific risk assessment in OHCA survivors without structural disease; leaves open whether dual induction testing should guide management.
BACKGROUND: Optimal therapy for patients resuscitated from out-of-hospital cardiac arrest (OHCA) who are not found to have structural heart disease remains to be established, especially regarding the use of implantable cardioverter-defibrillators. Coronary artery spasm (CAS) and lethal ventricular arrhythmias are important causes of OHCA. METHODS AND RESULTS: In 47 consecutive OHCA survivors without structural heart disease who had fully recovered (M/F 44/3, 43±13 years.), we performed dual induction tests, including acetylcholine provocation test first followed by programmed ventricular stimulation after 1 to 2 weeks. Patients with CAS were treated with calcium channel blocker-based antianginal medications; implantable cardioverter-defibrillators were implanted in all patients. The results of the dual induction tests defined 4 groups: CAS alone (n=7), inducible ventricular arrhythmias alone (n=13), both positive (n=24), and both negative (n=3). During a median follow-up period of 38 months, ventricular fibrillation recurred in all groups except the both-negative group. Of the 16 patients with a type I Brugada ECG, 2 had CAS alone, 8 had ventricular arrhythmias alone, and 6 had both positive. No ventricular fibrillation episodes were observed in the CAS-alone patients who did not also have Brugada syndrome. Kaplan-Meier analysis showed that the CAS-alone group was at lower risk for OHCA recurrence as compared with the Brugada syndrome group (log-rank test; P=0.036). CONCLUSIONS: Among OHCA survivors without structural heart disease, provokable CAS and ventricular arrhythmias are common and can be seen in Brugada syndrome. CAS alone without Brugada syndrome who are treated for CAS may be a lower-risk group.
No takes yet. Share an insight, caveat, or question.
Komatsu et al. (2016) conducted a cohort in Out-of-hospital cardiac arrest (OHCA) without structural heart disease (n=47). Coronary artery spasm (CAS) alone vs. Brugada syndrome was evaluated on OHCA recurrence (p=0.036). Among OHCA survivors without structural heart disease, patients with coronary artery spasm alone were at lower risk for OHCA recurrence compared with the Brugada syndrome group.
Synapse has enriched 10 related papers. Consider them for comparative context: